.png?#)
FDA's oncology adcomm to review GSK's Blenrep relaunch plans
The FDA’s Oncologic Drugs Advisory Committee will meet on July 17 to discuss a potential relaunch of GSK’s multiple myeloma drug Blenrep. The committee will consider GSK's application to bring Blenrep ...
The FDA’s Oncologic Drugs Advisory Committee will meet on July 17 to discuss a potential relaunch of GSK’s multiple myeloma drug Blenrep.
The committee will consider GSK's application to bring Blenrep ...
